Azo Reductase Activated Magnetic Resonance Tuning Probe with "Switch-On" Property for Specific and Sensitive Tumor Imaging in Vivo.
ACS Nano
; 17(23): 24384-24394, 2023 Dec 12.
Article
in En
| MEDLINE
| ID: mdl-37991343
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Nanoparticles
/
Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
ACS Nano
Year:
2023
Type:
Article
Affiliation country:
China